Chiu, T., Su, Y., Yang, S., Li, C., Bai, L., Chiang, N., . . . Chou, W. (2021). Liposomal irinotecan pre-emptive dose reduction in patients with pancreatic ductal adenocarcinoma: 667 patients’ experience within a population-based study. SAGE Publishing.
Cita Chicago Style (17a ed.)Chiu, Tai-Jan, et al. Liposomal Irinotecan Pre-emptive Dose Reduction in Patients with Pancreatic Ductal Adenocarcinoma: 667 Patients’ Experience Within a Population-based Study. SAGE Publishing, 2021.
Cita MLA (8a ed.)Chiu, Tai-Jan, et al. Liposomal Irinotecan Pre-emptive Dose Reduction in Patients with Pancreatic Ductal Adenocarcinoma: 667 Patients’ Experience Within a Population-based Study. SAGE Publishing, 2021.
Precaución: Estas citas no son 100% exactas.